Europe's Choice
Geopolitical shifts are reshaping life sciences. Europe can build on its strengths and lead or stand still and fall behind. What will it choose?
LEARN MOREHow can we ensure Europeans don't miss out on the latest advances in treatment?
EFPIA is asking EU leaders to work together with industry to create opportunities to, once again, make the region a world-leader in life sciences
EFPIA Code of Practice and relationships with patient organisations and healthcare professionals.
Latest Updates
VIEW ALL-
Statements & press releases 24.02.26
35,000 more patients to get access to clinical trials if new EU targets are met
New research from Frontier Economics, published today by EFPIA, shows that 35,000 Europeans will benefit from access to groundbreaking medical treatments...
Read Article -
EFPIA News 20.02.26
EFPIA response to the General Court ruling on the Urban Wastewater Treatment Directive
The General Court has dismissed EFPIA's action for annulment of the Urban Wastewater Treatment Directive (UWWTD) on the grounds of lack of legal standing. While...
Read Article -
EFPIA News 19.02.26
A comparative analysis of biopharmaceutical strategies in 10 countries
Biopharma is no longer just a health issue. It is a geopolitical and economic priority. In the global race for innovation, countries are investing in biotech...
Read Article -
External Event 19.03.26
J&J | The essentials of partnering with a pharma company
Discover what it takes to build successful collaborations with pharmaceutical companies and accelerate your innovation to patients.
View Event -
External Event 24.03.26
DIA Europe 2026
Join the DIA Europe 2026 in March to explore how Europe can bring and keep innovation into the system to deliver better outcomes for patients.
View Event -
EFPIA Event 21.04.26
Europe’s Choice: Investing in sustainable health systems
At a time when health budgets are strained, public finances are under pressure, the health workforce crisis is deepening, and Europe faces unprecedented...
View Event